Jeff Karp

Professor, Brigham & Women's Hospital, Harvard Medical School

Bioinspirationalist Dr. Jeff Karp is a translational leader in drug delivery, stem cell therapeutics, medical devices, & tissue adhesives. He is a Professor of Medicine at Brigham & Women’s Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, & an Affiliate Faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences & Technology.

He has published >100 peer-reviewed papers (>15,000 citations) & has given 270 national and international invited lectures & has 100 issued or pending patents. Karp has co-founded six companies including: Gecko Biomedical, Skintifique, Frequency Therapeutics, Alivio Therapeutics, Molecular Infusions, and Landsdowne Labs.

The Boston Business Journal recognized him as Champion in Healthcare Innovation & MIT’s Technology Review Magazine (TR35) recognized him as a top innovator in the world (3 members from his lab have received this award). Boston Magazine recently recognized Karp as one of 11 Boston Doctors Making Medical Breakthroughs.

His work was selected by Popular Mechanic’s “Top 20 New Biotech Breakthroughs that Will Change Medicine.” He gave a TEDMED talk on bioinspired medical innovation & is a member of the TEDMED Editorial Advisory Board. He has received two Breakthrough Awards from the Kenneth Rainin Foundation & was a commencement speaker at the University of Toronto.

He is frequently sought as an advisor on science/business to industry executives & scientists and has served as consultant or scientific advisory board member to >20 biotech, pharma, & med device companies. He serves as an expert witness in cases involving medical devices & biotechnology.

Dr. Karp was selected as the Outstanding Faculty Undergraduate Mentor among all MIT Faculty & he received the HST McMahon Mentoring award for being the top mentor of Harvard-MIT students. To date, 20 trainees from his lab have secured faculty positions & many others impactful positions in pharma & biotech industries.